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Study of Tricarboxylic Acid Cycle Flux Changes in
Human Visual Cortex During Hemifield Visual
Stimulation Using 1H-{13C} MRS and fMRI
Wei Chen,* Xiao-Hong Zhu, Rolf Gruetter, Elizabeth R. Seaquist, Gregor Adriany,
and Kamil Ugurbil
The relationships between brain activity and accompanying
hemodynamic and metabolic alterations, particularly between
the cerebral metabolic rate of oxygen utilization (CMRO2) and
cerebral blood flow (CBF), are not thoroughly established.
CMRO2 is closely coupled to the rate of tricarboxylic acid (TCA)
cycle flux. In this study, the changes in glutamate labeling
during 13C labeled glucose administration were determined in
the human brain as an index of alterations in neuronal TCA
cycle turnover during increased neuronal activity. Two-volume
1H-{13C} MR spectroscopy (MRS) of the visual cortex was com-
bined with functional MRI (fMRI) at 4 Tesla. Hemifield visual
stimulation was employed to obtain data simultaneously from
activated and control regions located symmetrically in the two
hemispheres of the brain. The results showed that the fractional
change in the turnover rate of C4 carbon of glutamate was
less than that of CBF during visual stimulation. The frac-
tional changes in CMRO2 (DCMRO2) induced by activation must
be equal to or less than the fractional change in glutamate
labeling kinetics. Therefore, the results impose an upper limit of
;30% for DCMRO2 and demonstrate: 1) that fractional CBF
increases exceed DCMRO2 during elevated activity in the visual
cortex, and 2) that such an unequal change would explain the
observed positive blood oxygenation level dependent (BOLD)
effect in fMRI. Magn Reson Med 45:349–355, 2001.
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Minimally invasive or noninvasive imaging techniques,
such as positron-emission tomography (PET), optical im-
aging, and BOLD-based fMRI (1–3) are employed with
increasing frequency in studies of brain function. These
methods, however, do not measure electrical activity of
the brain directly; instead, they rely on secondary meta-
bolic and hemodynamic responses. The preeminence of
these imaging techniques in contemporary neuroscience
research has highlighted the fact that many aspects of
these metabolic and hemodynamic responses remain
poorly understood and controversial. The central question
in this controversy is the effect of elevated neuronal activ-
ity on regional cerebral metabolism of oxygen utilization
rate (CMRO2).
Under resting conditions, total glucose consumption
rate in the brain (CMRglc) is well coupled to CMRO2 and to
cerebral blood flow (CBF) in the human brain (4), and
occurs predominantly through oxidation. However, it has
been suggested that this may not be the case during in-
creased neuronal activity. Based on PET measurements,
the increases of CMRO2 (0–5%) were reported to be much
less than the elevation in CBF and CMRglc (40–51%) dur-
ing visual and somatosensory stimulation, suggesting that
CMRO2 is “uncoupled” from CBF and CMRglc in the acti-
vated state (5,6). This concept, however, is counterintui-
tive in view of the large aerobic capacity in the brain. The
difficulties associated with PET, which relies on multiple
independent measurements and intersubject averaging to
determine CMRO2, have also contributed to the skepticism
about the validity of this concept. Because of this complex-
ity, only a few such PET measurements have been re-
ported, with discrepant conclusions.
Resolution of this problem requires new studies on
CMRO2, especially using techniques that are dependent on
entirely new mechanisms. Measurements in a single sub-
ject within a single experiment are also crucial in order to
avoid large variances generated by intersubject averaging.
Cerebral oxygen consumption is coupled to tricarboxylic
acid (TCA) cycle flux, which can be assessed using MR
spectroscopy and 13C-labeled substrate infusion. The tech-
nique relies on measuring the isotopic turnover rate of
glutamate (Glu) from infused [1-13C] labeled glucose using
direct detection of 13C or indirect detection through cou-
pled protons (1H-{13C} MRS technique) (7–9). These ap-
proaches have been used for basal measurements of TCA
cycle turnover rate in the human brain (8,9) and changes
associated with forepaw electrical stimulation in animal
studies (10).
The availability of high magnetic fields provides the
possibility for the first time that similar spectroscopic
techniques (7) can be employed simultaneously with im-
aging to determine metabolic consequences of elevated
neural activity in the awake human brain in single sub-
jects. In this work, we report the results of such a study
conducted at 4 Tesla using a two-volume 1H-{13C} MRS
technique combined with fMRI and hemifield visual stim-
ulation that selectively activates the primary visual cortex
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(V1) area in the contralateral hemisphere. The data were
analyzed using a model accounting for glial and neuronal
compartments to determine the impact of activation on the
rate of neuronal pyruvate dehydrogenase, VPDH, as a mea-
sure of neuronal TCA cycle activity, and therefore oxygen
utilization rate in the brain.
MATERIALS AND METHODS
Visual Stimulus
The hemifield visual stimulus with reversal checkerboard
pattern (full visual field 5 44° width 3 34° height) was
presented on a screen inside a magnet which could be
viewed by subjects via a mirror. The checkerboard was
reversed at an 8-Hz frequency between red and black col-
ors. The side of the hemifield visual stimulation was ran-
domly chosen for different subjects. A small cross-shaped
marker at the center served as a central fixation point, and
the orientation of this marker was rotated by 45° at random
intervals. Subjects were asked to maintain fixation on the
marker during both control and task periods, and to re-
spond to the rotation of the marker by pressing a button.
The responses were evaluated, and the correct response
rates were above 90%.
Human Studies
Five healthy subjects (two males and three females, 26–31
years of age, average 29 years) without history of neuro-
logical disorders participated in this study, which was
approved by the institutional review board of the Univer-
sity of Minnesota. Prior to the experiment, subjects were
prepared for the study with the placement of intravenous
catheters in each arm. Somatostatin was infused at a rate of
0.16 mg/kg/min through one catheter, and glucose was
infused through the other. A third catheter was placed in
the distal leg for the collection of blood samples every
5 min. When baseline sampling was complete and hemi-
field visual stimulation and MRS acquisition were started,
subjects were given a bolus injection of 30 g of 99% en-
riched [1-13C] D-glucose (20% weight/volume), according
to recently-described procedures (9). Plasma glucose was
then maintained at the peak level by the infusion of 70%
enriched [1-13C] D-glucose (20% weight/volume) at a vari-
able rate. After 20 g of additional [1-13C] D-glucose had
been infused (or approximately 20 min after the bolus
injection), all glucose infusions were stopped and plasma
glucose was allowed to decrease to baseline. 1H-{13C} MRS
data were obtained during the entire infusion period
(74–90 min for four subjects and 48 min for subject 3) with
hemifield visual stimulation.
NMR Experiments
All studies were conducted on a Varian (Palo Alto, CA)
console interfaced to a Siemens (Erlangen, Germany)
4 Tesla whole body MRI/MRS system. The same surface-
coil probe was used for both fMRI and MRS measure-
ments, consisting of a 10-cm single loop surface coil with
distributed capacitance for 1H excitation and reception
and two 15-cm surface coils in quadrature mode for 13C
spin inversion and decoupling. A 1-cm diameter sphere
containing [13C]-formic acid was placed at the center of the
1H coil for calibrating the 13C-radiofrequency power. Mul-
tislice (128 3 128 matrix size) T1-weighted turbo fast low-
angle shot (turboFLASH) images were acquired for ana-
tomical information.
Functional MRI Acquisition
An fMRI study was performed on each subject using the
hemifield visual stimulation prior to the 13C measure-
ments. The purpose of these initial fMRI examinations
was: 1) to ensure that the hemifield visual stimulation only
activated the V1 area in the contralateral hemisphere; and
2) to determine the location and size of the activated area,
based on which the localized volume for spectroscopy was
specified. Seven contiguous coronal slices covering the
calcarine fissure were acquired using a gradient echo-pla-
nar imaging (EPI) sequence (64 3 64 image matrix size,
20 3 20-cm2 field of view, 5-mm slice thickness, TE 5
25–38 msec, TR 5 2 sec). Three control periods and two
task periods were designed in an interleaved way;
20 image sets were acquired in each of the five consecutive
periods, resulting in a total of 100 multislice image sets.
Prior to 2D Fourier transformation, the k-space imaging
data was apodized with Gaussian filtering to improve the
signal-to-noise ratio (SNR), resulting in a ;0.3 pixel in-
crease in pixel size at full width at half maximum (FWHM)
(11). Time courses were analyzed using functional imaging
software STIMULATE, developed in our laboratory. Acti-
vation maps were generated by statistical parametric map-
ping using the period cross-correlation statistic method
(12). “Activated” pixels were determined by requiring that
the cross-correlation coefficient (cc) was 0.3 or higher, and
a four-pixel neighborhood cluster was present. Using a
method (11) that accounts for the 1) cluster size threshold
(5 4); 2) threshold of statistical significance (t or z value 5
3.05); 3) smoothness due to the Gaussian filtering; and 4)
total number of pixels in the searched brain area (;
1000 for a single slice), the effective P value was calculated
to be 0.017. The fMRI maps were used for guiding the
voxel position of the localized 1H-{13C} MRS and for cal-
culating the fractional activation volume (FAV) within the
voxel. The values of FAV were used for partial volume
correction for calculating the relative changes of CMRO2
during visual stimulation. Potential differences in gray
matter content in the voxels was assumed to be negligible,
given the symmetric placement of the volume of interest
(VOI) relative to the central sulcus and the symmetry of
normal brain.
1H-{13C} MRS Measurements
The measurements of glutamate labeling kinetics were
based on the 1H-{13C} MRS technique (7,8), implemented
as described previously (7). Briefly, the pulse sequence
consisted of: 1) spatial localization using point-resolved
spectroscopy (PRESS) (13), 2) outer volume suppression
combined with water suppression, 3) a 13C inversion pulse
(0.56 msec) centered at 1/(2JCH) ; 4 msec for heteronuclear
editing, and 4) Wideband Alternating-phase Low-power
Technique for Zero-residual splitting decoupling
(WALTZ)-16 pulses for broadband 13C decoupling. The
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average specific absorption rate (SAR) for the entire pulse
sequence was below the FDA guideline. Subtractions of
the two free induction decays (FIDs) acquired in the pres-
ence and absence of the 13C inversion pulse yielded edited
spectra containing only signals from protons coupled to
13C nuclei (8). Additions of these paired FIDs resulted in
1H spectra containing signals from protons attached to 12C
spins only. In this study, the pulse sequence (7) was fur-
ther modified based on the concept of multivolume local-
ization for simultaneous detection of two 1H-{13C} spectra
from two adjacent localized volumes in a single experi-
ment. This was accomplished by adding an adiabatic in-
version pulse that was only used during alternate block
acquisitions of 1H-{13C} spectra; this adiabatic pulse in-
verted half of the original localized volume along the di-
rection perpendicular to the central fissure. Addition and
subtraction of these two interleaved block data provided
two 1H-{13C} spectra (mainly containing the 1H resonance
peaks of Glu C4) from the two adjacent V1 areas located in
the left and right hemispheres, respectively (1.5 3 2.0 3
2.0 5 6 cm3 each side). Spectral parameters were: TE 5
23 msec, TR 5 3 sec, 2048 complex data points, 4000 Hz
spectral width, and 64 scans for each pair of 1H-{13C}
spectra from the left- and right-hemisphere V1 areas. Prior
to fast Fourier transformation, the FID was zero-filled and
multiplied with an exponential function corresponding to
a 1-Hz line broadening. The edited 1H-{13C} spectra were
used for integrating the proton resonance peaks from Glu
13C4 (2.20–2.45 ppm), Glu 12C4 (2.20–2.45 ppm), and 12C
total creatine (i.e., tCr) (2.9–3.1 ppm), respectively. A lin-
ear baseline correction was applied prior to the integra-
tion.
The averaged 1H-{13C} spectra from the last 8–12 spectra
were used to calculate fractional enrichment (FE) of 13C
labeled Glu C4 based on the equation of FE 5 [Glu 13C4]/
([Glu 13C4] 1 [Glu 12C4]) for both activated and control
voxels. Generally, the NMR sensitivities of detection by
the surface coil between the left- and right-hemisphere V1
regions were not identical, as expected. To determine
whether the steady-state concentrations of Glu 12C4 and
Glu 13C4 were the same on both sides, we compared the
relative signal of tCr (i.e., tCr(left voxel)/ tCr(right voxel)) to the
analogous ratios calculated for the Glu 12C4 and Glu 13C4
resonances. Linear regression yielded a unit slope for both
comparisons (slope 5 0.95, correlation coefficient g 5
0.99, and P 5 0.01 for the [tCr] ratio vs. [Glu 12C4] ratio;
and slope 5 1.06, correlation coefficient g 5 0.98, and P 5
0.02 for the [tCr] ratio vs. [Glu 13C4] ratio). Assuming that
total creatine content does not change during visual stim-
ulation and is the same at both locations, we concluded
that [Glu 13C4] and [Glu 12C4] at steady states were similar
between the activated and control voxels. Therefore, the
steady state of Glu 13C4 signal intensities were used to
normalize the Glu 13C4 intensities at all time points, and
these normalized curves were then used.
Calculation of Fractional Change in Neuronal Pyruvate
Dehydrogenase Rate (VPDH)
The normalized glutamate [4-13C] labeling data were ana-
lyzed for fractional changes in the rate of neuronal pyru-
vate dehydrogenase (VPDH). This was accomplished using
a two-compartment model (Ref. 9 and references therein)
that accounts for glial/neuronal compartmentation of the
TCA cycle with large (neuronal) and small (glial) gluta-
mate pools. Neuronal VPDH dominates carbon substrate
entry into the neuronal TCA cycle in the virtual absence of
anaplerosis in the neuronal compartment (Ref. 9 and ref-
erences therein), especially when only the C4 carbon of
glutamate is monitored, as was done in this study. There-
fore, fractional changes in VPDH reflect fractional changes
of neuronal TCA cycle rate in tissue. The analysis for
determining this fractional change was performed with or
without modeling possible effects of increased glucose
consumption rate on the 13C fractional enrichment kinet-
ics of the cerebral glucose pool.
Label turnover of brain glucose was either assumed to be
independent of the glucose consumption rate or the effect
of brain glucose turnover (14) was evaluated from the
kinetic constants of the reversible Michaelis-Menten
model of glucose transport (15). The latter was achieved
similarly to previous studies (9,16) by solving the corre-
sponding differential equations for changes in total brain
glucose and 1-13C brain glucose to generate a curve de-
scribing the change in fractional enrichment of pyruvate,
assuming a 1 mmol/g brain lactate concentration (17). A
potential 50% increase in brain lactate was assumed to
have a negligible impact on the labeling of acetyl-CoA,
given the high activity of lactate dehydrogenase (LDH) and
the high surface area of the brain cell membranes.
The following assumptions were used in the two-com-
partment model for the determination of VPDH: The ex-
change rate between mitochondrial a-ketoglutarate and
cytosolic glutamate, Vx, was assumed to be 57 mmol/g and
[Glu] 5 9.0 mmol/g. The assumption that a-ketoglutarate
and glutamate exchange is very fast was based on previous
reports in brain (16,18). This assumption may not be true
in all tissues and under all conditions, as was shown in the
heart. Therefore, we also evaluated the case in which the
exchange rate Vx was equal to the flux through the neuro-
nal TCA cycle. The flux through (glial) glutamine syn-
thetase Vsyn was set to ;0.25 mmol/g/min, which is the
rate of glutamine synthesis reported with a one-compart-
ment model (referred to as VGln in that model) (16), and the
rate of the glial enzyme pyruvate carboxylase, Vpc, was set
to 20% Vsyn (9,19). For fitting, Glu was normalized and
expressed as a percentage of the steady-state signal.
The following two metabolic rates were adjusted to pro-
vide the best fit to the experimental data: 1) the rate of label
dilution by efflux of lactate and pyruvate, Vout, and 2)
(neuronal) VPDH. Vout accounts for a decreased fractional
enrichment in Glu relative to half that of plasma glucose
(10).
Partial Volume Correction of VPDH Calculation
The partial volume correction for VPDH observed by fMRS
is given by
VPDH,Observed 5 FAV z VPDH,Activated 1 ~1 2 FAV!VPDH,Control [1]
where VPDH,Observed, VPDH,Activated, and VPDH,Control are the
VPDH rates detected during the visual stimulation before
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and after the partial volume correction and during resting
condition, respectively. Based on the definitions of
SDVPDHVPDH DObserved or Corrected 5
VPDH, Observed or Activated 2 VPDH, Control
VPDHControl
[2]
one can get a simple relationship between corrected and
observed values of DVPDH/VPDH using Eq. [1]
SDVPDHVPDH DCorrected 5
1
FAV
SDVPDHVPDH DObserved. [3]
All data are presented as mean 6 SEM.
RESULTS
Sustained Response During Prolonged Stimulation
Most fMRI studies use relatively short task periods (0.5–1
min). However, MRS experiments for investigating meta-
bolic changes during functional activity (10), and the
present experiments require relatively long data acquisi-
tion periods (on the order of 40–60 minutes) and, ulti-
mately, long stimulation duration. Interpretation of these
long functional experiments requires an understanding of
the metabolic and neuronal activity changes during sus-
tained stimulation. We previously reported that the BOLD
effect remained detectable during sustained visual stimu-
lation (up to 15 min) in the human brain (20). Prior to the
spectroscopy studies reported in this work, we used the
flow-sensitive alternating inversion recovery (FAIR) perfu-
sion technique (21) to reexamine whether CBF remains
increased during a sustained hemifield visual stimulation
(20–30 min). Figure 1 illustrates CBF data from an indi-
vidual subject. The results indicated that a significant CBF
increase in the activated V1 areas (contralateral hemi-
sphere) persists during the entire stimulation period
(20 min). No significant increase of CBF was observed in
the control V1 areas. Therefore, it is feasible to utilize MRS
for studying metabolic response during a sustained visual
stimulation in the human brain.
Functional MRI and 1H-{13C} MRS
In each subject, selective V1 activation of the contralateral
hemisphere by hemifield stimulation was experimentally
verified by fMRI. Figure 2 illustrates multislice fMRI maps
(two contiguous coronal slices) from a single subject dur-
ing left hemifield stimulation, showing activation only in
the contralateral (right) hemisphere (Fig. 2a). The in-plane
activation size was approximately 2 3 1.5 cm2 and was
similar to the size used for 1H-{13C} MRS studies (the
dark-line box in Fig. 2a). Figure 2b displays the BOLD time
courses from the activated V1 (top line, ;5% BOLD in-
crease) and control V1 (lower line) from the same subject.
There was no significant BOLD response in the control V1
area (the white-line box in Fig. 2a). These fMRI maps were
also used to calculate FAV (see Methods section) in the
activated V1 for each subject, as listed in Table 1. The
conservative choice of the statistical significance for the
activation threshold employed in these studies implies
that the reported FAV is a lower limit of the activated
volume measured by BOLD fMRI. Nevertheless, the aver-
aged FAV was high (0.81 6 0.09, N 5 5).
Figure 3 displays the plots of serial 1H-{13C} spectra
(64 scans, 3-min acquisition time and 6-cm3 localized vol-
ume) of [4-13C] Glu obtained from the activated (Fig. 3a)
and control (Fig. 3b) V1 areas, respectively, during hemi-
field visual stimulation and concomitant [1-13C] glucose
infusion from a single subject. [4-13C] Glu isotopic labels
from both the activated and control V1 areas increased as
a function of infusion time at a similar rate, suggesting that
small (if any) differences in metabolism were present be-
tween the hemispheres. The steady-state FE of [4-13C] Glu
FIG. 2. a: Functional MR images (two contiguous coronal slices)
from a single subject during the left hemifield visual stimulation. The
stimulation activated the V1 areas in the contralateral (right) hemi-
sphere alone. b: BOLD time courses from the activated V1 (top line,
;5% BOLD increase, the dark-line box) and control V1 (lower line,
the white-line box). The boxes indicate the voxel volumes (2 3
1.5 cm2) and positions used for 1H-{13C} MRS studies. The symbols
L and R represent the left and right hemispheres, respectively. The
dark bars indicate the task periods of visual stimulation.
FIG. 1. Time courses of CBF change from the activated V1 (solid
circles) and control V1 (open circle). The dark bar indicates the task
period of visual stimulation.
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was not statistically different (P 5 0.16 for paired t-test)
between the activated V1 (18.2 6 0.6; N 5 5) and control
V1 (17.2 6 0.8; N 5 5) (see Table 1).
Calculation of VPDH Changes
The time courses of [4-13C] Glu isotopic labeling from the
activated and control V1 areas and the best fits of the
metabolic modeling to the data from the same subject (Fig.
3) are shown in Fig. 4a. Figure 4b illustrates the analogous
time courses and the best fits obtained after averaging the
results from all subjects (N 5 5). A slightly faster rate of
[4-13C] Glu isotopic labeling was observed on the activated
side for all individuals, as well as for the intersubject
averaged data.
Metabolic modeling (see Methods section) indicated
that VPDH was 0.83 6 0.13 mmol/g/min under basal con-
ditions, consistent with measurements of glucose con-
sumption rate (CMRglc 5 0.42 mmol/g/min in the human
visual cortex (6)), and increased to 1.12 6 0.20 mmol/g/min
(mean 6 SEM) during visual stimulation. When calculated
in this way, VPDH did not statistically differ between acti-
vated and nonactivated voxels because of the large inter-
individual scatter. However, because of the paired nature
of our study design, a more reliable comparison based on
the fractional changes in VPDH was performed. This anal-
ysis showed that VPDH in the activated volume relative to
Table 1
Summary of Glutamate Turnover Rate Changes in the Human Brain During Visual Stimulation
Subject
Activated
hemisphere
Fractional enrichment (%)
Fav
Increase of [4-13C]
Glu turnover rate (%)Activated Control
1 Left 19.3 18.2 0.88 0.20
2 Right 17.1 18.3 1.00 0.28
3 Right 16.5 14.0 0.90 0.75
4 Left 19.0 17.5 0.70 0.14
5 Left 19.2 17.8 0.50 0.01
Mean 18.2 17.2 0.81 0.28
SEM 0.6 0.8 0.09 0.12
FIG. 3. Stack plots of 1H-{13C} spectra of [4-13C] Glu (3.2-min
acquisition time per trace, 6-cm3 voxel size) after [1-13C] glucose
infusion and the hemifield visual stimulation from (a) activated and
(b) control V1 voxels.
FIG. 4. Turnover curves of [4-13C] Glu isotopic labeling (symbols)
and the best fits of the metabolic modeling to the turnover curves
(lines). a: Results from a single subject (solid circles and solid line:
activated V1 voxel; open circles and gray line: control V1 voxel). b:
Intersubject averaged results (solid circles and solid line: activated
V1 voxel; open circles and gray line: control V1 voxel; N 5 5).
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the control side was increased by 28612% (based on in-
dividual subject data, which are summarized in Table 1) or
30% (based on intersubject averaged curve) and this was
independent of whether Vx was assumed to be fast relative
to TCA cycle turnover rate or equal to it. This 28612%
increase changed to 31614% after applying partial volume
corrections (Eq. [3]).
DISCUSSION
By taking advantage of high sensitivity at high magnetic
fields, we have successfully used the two-volume 1H-{13C}
MRS method and fMRI to measure metabolic changes cou-
pled to neuronal activity in single subjects within the same
experimental session, and from small volumes (6 ml) with
a small partial volume effect. The advantage of hemifield
stimulation resulted in an inherently paired study, thereby
eliminating potential differences in turnover curves be-
tween control and activated states when measured at dif-
ferent times and/or subjects. Therefore, these measure-
ments represent a robust estimate of alterations in gluta-
mate turnover, reflecting the actual effect due to brain
activation.
Glutamate labeling occurs through the TCA cycle. Tak-
ing Vx, the rate of exchange between mitochondrial a-ke-
toglutarate and cytosolic glutamate, to be either signifi-
cantly fast relative to TCA cycle turnover rate or equal to it,
the fractional increase of VPDH was ;30% (depending on
partial volume correction), assuming the effect of a finite
turnover of brain glucose on isotope kinetics to be negli-
gible (10). Fractional enrichment kinetics of brain glucose
or total brain glucose consumption (CMRglc) rate cannot be
measured separately from Glu turnover alone. To assess
the influence of brain glucose turnover, we considered the
effect of a 50% increase in CMRglc, as reported previously
(6), on the 13C enrichment of pyruvate using the reversible
Michaelis-Menten model of glucose transport (15). This
reduced the calculated change in VPDH to –267% (aver-
aged from individual fits) or 1% (when fitting to the aver-
aged time course) without partial volume correction. As-
suming a 25% increase of CMRglc, (similar to that reported
by 1H MRS from somewhat larger volumes during visual
stimulation (22)), yielded an increase in VPDH of 10610%
(averaged from individual fits) or 7% (fitting from averaged
data) when glucose turnover was considered in the mod-
eling. It should be stressed that the mathematical covari-
ance between CMRglc and VPDH is expected to result in an
increase in CMRglc on the order of 15%, when assuming
that all of the glucose is completely oxidized.
Independent of whether the metabolic modeling in-
cluded glucose label turnover, our study shows that the
upper limit on changes in VPDH is ;30%. Assuming the
neuronal TCA cycle flux rate to be stochiometrically cou-
pled to CMRO2 the study also provides an upper limit in
cerebral oxygen consumption measurements. Unless the
P:O ratio is altered in the brain during visual activation,
the stochiometry of coupling between TCA cycle rate and
CMRO2 is expected to be constant. A change in the P:O
ratio is unlikely to occur in the brain under the conditions
of our study. Small changes in the P:O ratio do take place
in tissues such as the heart when fatty acids are the dom-
inant carbon source, since fatty acids can act as mitochon-
drial “uncouplers.” However, this is not expected in the
brain, where glucose is the dominant carbon source for
energy metabolism. Hence, the percentage increase in neu-
ronal TCA cycle rate should be approximately equal to the
percentage increases in CMRO2 induced by elevated neu-
ronal activity; therefore, our data provide an upper limit of
;30% for CMRO2 increase due to visual stimulation.
It is well accepted that the total glucose consumption
rate is tightly coupled to CBF at both resting and func-
tionally activated conditions, and both increase ;50%
in the V1 areas during visual stimulation (6). Therefore,
independent of the constraints and assumptions made
in modeling, our results indicate that the CMRO2
changes accompanying increases in neuronal activity
are not stochiometrically coupled to CBF and CMRglc
enhancements. This conclusion is qualitatively consis-
tent with several PET studies (e.g., Ref. 6), and further
supports the concept that fractional elevation in glucose
consumption exceeds that in the oxygen consumption
rate during visual stimulation. The difference may be
accounted for by brain glycogen, which is present in
significant amounts in the central nervous system (23);
however, the quantitative significance of brain glycogen
metabolism on these findings remains to be ascertained.
If brain glycogen metabolism was unchanged, the results
imply that excess pyruvate was formed during visual
stimulation, most of which must be exported from the
brain cells as lactate. Small increases in cerebral lactate
have been reported (17).
In principle, CMRO2 can be quantified based on funda-
mental BOLD theory (e.g., Ref. 24) and/or can be calcu-
lated from independent measurements on BOLD, CBF, and
cerebral blood volume (CBV) using BOLD modeling (re-
view in Ref. 25). This approach was used for visual stim-
ulation under a single set of conditions, yielding estimates
of DCMRO2 between 5% and 30% (26,27). When graded
stimulation was employed (28), similar calculations pre-
dicted that fractional increases in CMRO2 and CBF are
related with a slope of ;0.5. However, experimental de-
termination of all the parameters involved in linking
BOLD to CMRO2 is so far incomplete, especially in the
same subject and under the same set of conditions. The
validity of the procedures employed for calibrating some
of these parameters using hypercapnia (26–28) remains
questionable, since vasodilatation induced by hypercap-
nia appears to differ significantly from that generated by
neuronal stimulation with respect to the type and size of
the vessels that are dilated. Despite the ambiguities asso-
ciated with BOLD modeling, however, the range of results
reported by the BOLD modeling are qualitatively in agree-
ment with the relative CMRO2 change obtained in the
present study.
A previous study reported a large increase of CMRO2 of
250% in the somatosensory cortical areas of the anesthe-
tized rat brain during forepaw electric stimulation (10).
This CMRO2 increase is much greater than the values we
observed in the visual cortex of the awake human during
visual stimulation, and was much larger than that pre-
dicted by most models of the BOLD effect. One possible
explanation is that in the resting anesthetized state, the
metabolic rates are significantly lower than in the resting
awake state, whereas the final values attained during neu-
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ronal activation are similar for the anesthetized and non-
anesthetized brain (29).
CONCLUSIONS
Based on the quantitative measurements of both metabolic
and hemodynamic responses using the 1H-{13C} MRS and
fMRI techniques at 4 Tesla in the human visual cortex
during hemifield visual stimulation, the fractional change
of VPDH and hence CMRO2 was less than ;30% and less
than fractional increases in CBF. The exact number for
VPDH, and hence CMRO2 change, however, strongly de-
pend on alterations on glucose-labeling kinetics induced
by neuronal stimulation and consequent increase in total
glucose consumption rate. Irrespective of this confounding
factor, it is possible to conclude that the coupling between
CMRO2 and CBF changes during focal physiologic neural
activity in the human brain is less than unity. This sup-
ports the notion that alterations during functional activa-
tion would lead to a decrease in regional deoxyhemoglo-
bin content and, ultimately, a positive BOLD effect in fMRI
(Ref. 25 and references therein).
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